The nation of Zimbabwe has declined a major US health deal worth $367m (272 million pounds) spanning five years because of Washington's insistence on sensitive biological samples.
The decision became public after a official document from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesman later explained that the United States was demanding access to genetic material for research and profit but refused to guarantee the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for continued negotiations to reach a deal acceptable to both sides so the nation's vital HIV programme can be sustained.
Broader Implications
Zimbabwe's decision comes after a similar situation in Kenya, where a court halted a related deal with the US after concerns were raised about the safety of Kenyans' health data.
After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
Based on statements, 16 nations in Africa have to date agreed to these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"In essence, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our population should a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one deals were undermining frameworks already set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future collaboration might be structured in a manner that respects the sovereignty and interests of each country."
Health Experts Response
Medical experts expressed it understood the government's concerns, but urged that talks should continue considering much of the nation's Aids initiatives were funded by international support.
"In cases where technical issues arise, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group commented.
The situation emphasises the continuing challenges between accepting crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.